Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03481270 · ClinicalTrials.gov registry record · NA
The Oakland Men's Health Disparities Study
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,374
- Enrollment target
NCT03481270: Completed NA study, sponsored by Stanford University.
NCT03481270 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,374 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03481270, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,374 participants
- Enrollment target
Study Summary
Reducing racial disparities in health outcomes is a major policy concern in the United States. Although there has been recent progress to close the gap, black men continue to experience earlier morbidity and mortality from preventable and manageable medical conditions, and live on average 4.2 years less than their white male peers. An oft-prescribed solution to close this stubborn gap is to increase the diversity of the healthcare workforce. Another common policy tool to increase take-up of preventative healthcare services is financial incentives. In this randomized evaluation, we will estimate the effects of financial incentives and a racially concordant physician on the uptake of preventive health services in Oakland, California.
Primary Outcome
Take-up of preventative services was scored as either zero (did not utilize any post-consultation services) or 1 (utilized at least 1 post-consultation service). Four non-incentivized post-consultation preventive services were offered (for BMI, blood pressure, cholesterol, and/or diabetes); the subject had the opportunity to select service(s) after meeting with their assigned doctor.
Interventions
- BEHAVIORAL Concordant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,374 participants |
| Start Date | 2017-10-14 |
| Est. Completion | 2018-03-03 |
| Phase | NA |
What the finished NCT03481270 record still lists
NCT03481270 is an interventional study that assigns participants to a tested intervention. Its 1,374 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Concordant is the first listed.
NCT03481270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03481270 about?
NCT03481270 is a clinical study titled "The Oakland Men's Health Disparities Study". Reducing racial disparities in health outcomes is a major policy concern in the United States. Although there has been recent progress to close the gap, black men continue to experience earlier morbidity and mortality from preventable and manageable medical conditions, and live on average 4.2 years ...
What is the current status of trial NCT03481270?
This trial is currently completed. It is a NA study. The enrollment target is 1,374 participants. The study started on 2017-10-14. Estimated completion is 2018-03-03.
What interventions are being tested in trial NCT03481270?
The interventions under investigation include: Concordant (BEHAVIORAL).
Who is sponsoring clinical trial NCT03481270?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03481270's enrollment target sits among peer trials
1,374 73rd of 2000 higher than 1,928 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
- NCT06651281 · 1,380 participants · Phase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI